Manufacturing & Bioprocessing - software & AI news

Daily news on software, AI, and companies shaping manufacturing & bioprocessing.

Showing 63 results
A vial of biologics in a lab setting

May 1, 2026

Is Thermo Fisher’s New U.S. Bioprocess Design Center Shaping a Deeper Biopharma Strategy for TMO?

Thermo Fisher Scientific has launched its U.S. Bioprocess Design Center in Plainville, Massachusetts, aimed at enhancing its biopharma strategy by expanding lab and training facilities for biologics development.This new center adds 4,000 square feet dedicated to supporting the creation and scaling of biologics, such as vaccines and cell and gene therapies. By integrating its comprehensive bioproduction solutions with specialized onsite personnel, Thermo Fisher aims to streamline the transition f
A minimalist illustration of a bioreactor and monoclonal antibodies in a dark palette.

Apr 29, 2026

BPI Europe: Intensification is dropping the cost of up- and downstream mAb-making

At the BioProcess International Europe event, industry expert Jean-Marc Cappia emphasized the transformative impact of process intensification on monoclonal antibody (mAb) manufacturing, highlighting significant cost reductions and efficiency improvements.Cappia outlined how the integration of advanced technologies like single-use systems, perfusion bioreactors, and continuous capture platforms has driven down production costs from approximately $500 per gram to under $100 per gram in the last d
Close-up of biologics vials in a lab setting

Apr 24, 2026

AbbVie’s US$1.4b AI-Powered Campus Reshapes Immunology And Neuroscience Story

AbbVie is set to invest $1.4 billion in a new pharmaceutical manufacturing campus in North Carolina, focusing on immunology, neuroscience, and oncology. This facility will leverage advanced technologies and AI to enhance production efficiency and quality control for complex biologics.This significant investment marks AbbVie’s largest single facility commitment to date and is poised to create hundreds of skilled jobs. The move reflects a broader trend in the pharmaceutical industry to bolster dom